Julie C. Crockett

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy.

A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy.

Journal: CNS drugs

Published: May 01, 2020

A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam.

A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate Potential Drug-Drug Interactions Between Cannabidiol and Clobazam.

Journal: Journal of clinical pharmacology

Published: November 22, 2019

Abrupt withdrawal of cannabidiol (CBD): A randomized trial.

Abrupt withdrawal of cannabidiol (CBD): A randomized trial.

Journal: Epilepsy & behavior : E&B

Published: October 28, 2019

A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.

A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.

Journal: Epilepsia

Published: August 13, 2019

A Phase 1, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment.

A Phase 1, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment.

Journal: Journal of clinical pharmacology

Published: November 26, 2018

A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects.

A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects.

Journal: Clinical pharmacology in drug development

Published: October 05, 2018

Binding of αvβ3 Integrin-Specific Radiotracers Is Modulated by Both Integrin Expression Level and Activation Status.

Binding of αvβ3 Integrin-Specific Radiotracers Is Modulated by Both Integrin Expression Level and Activation Status.

Journal: Molecular imaging and biology

Published: July 12, 2017

RANK receptor oligomerisation in the regulation of NFκB signalling.

RANK receptor oligomerisation in the regulation of NFκB signalling.

Journal: Journal of molecular endocrinology

Published: May 27, 2014

Upregulation of endogenous farnesyl diphosphate synthase overcomes the inhibitory effect of bisphosphonate on protein prenylation in Hela cells.

Upregulation of endogenous farnesyl diphosphate synthase overcomes the inhibitory effect of bisphosphonate on protein prenylation in Hela cells.

Journal: Biochimica et biophysica acta

Published: October 16, 2013

Osteoporosis - a current view of pharmacological prevention and treatment.

Osteoporosis - a current view of pharmacological prevention and treatment.

Journal: Drug design, development and therapy

Published: May 30, 2013

RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations.

RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: January 25, 2012

Transfection of osteoclasts and osteoclast precursors.

Transfection of osteoclasts and osteoclast precursors.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: December 02, 2011

Showing 1-12 of 16

Last Updated: 09/26/2026